Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Microarray Market Size Cardiovascular Health Supplements Market Size Cell Therapy Technologies Market Size Targeted Protein Degradation Market SizeGlobal G-protein Coupled Receptors Market Size to Exceed USD 6.22 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global G-protein Coupled Receptors Market Size Expected to Grow from USD 3.25 Billion in 2023 to USD 6.22 Billion by 2033, at a CAGR of 6.71% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global G-protein Coupled Receptors Market Size, Share, and COVID-19 Impact Analysis, By Product (Cell Lines, Detection Kits), By Application (Cancer Research, CNS Research), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
The G-protein coupled receptors (GPCR) market is the industry dedicated to the research, development, and marketing of drugs, assays, and technologies targeting G-protein coupled receptors, which are important membrane proteins engaged in cellular signaling. GPCRs are of vital importance to numerous physiological processes and are one of the main targets for drug discovery in cardiovascular, neurological, metabolic, and immune disorders treatment. Moreover, the G-protein coupled receptors (GPCR) market is propelled by growing drug discovery processes against GPCR-associated diseases such as cardiovascular, neurological, and metabolic disorders. Improved biotechnology, AI-assisted drug screening, and high-throughput screening technologies improve the efficiency of research. Increased demand for precision medicine, increased healthcare investment, and increased pharmaceutical R&D expansion further drive market growth. The rising incidence of chronic diseases also accelerates the demand for new GPCR-targeting therapies. However, difficulty in high research expenditure, intricate structures of GPCRs, and issues with drug specificity are drawbacks that impede market growth. Regulatory barriers, possible side effects, and few successful clinical trials also limit the growth of therapeutics targeted to GPCRs.
The cell lines segment accounted for the largest share of the global G-protein coupled receptors market in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of product, the global G-protein coupled receptors market is divided into cell lines and detection kits. Among these, the cell lines segment accounted for the largest share of the global G-protein coupled receptors market in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is because of their widespread application in drug research, screening, and biomedical research. They offer a robust platform for examining GPCR functions, allowing pharmaceutical companies and research organizations to design effective targeted therapeutics with ease, propelling their leading market dominance.
The cancer research segment accounted for a substantial share of the global G-protein coupled receptors market in 2023 and is anticipated to grow at a rapid pace during the projected period.
On the basis of the application, the global G-protein coupled receptors market is divided into cancer research, and CNS research. Among these, the cancer research segment accounted for a substantial share of the global G-protein coupled receptors market in 2023 and is anticipated to grow at a rapid pace during the projected period. This is because of heightened interest in therapies targeting GPCR for the treatments of different forms of cancer. GPCRs are involved in tumor development, metastasis, and drug resistance, prompting intensified research activities and pharmaceutical investments for the discovery of new cancer medications.
North America is projected to hold the largest share of the global G-protein coupled receptors market over the projected period.
North America is projected to hold the largest share of the global G-protein coupled receptors market over the projected period. This is led by robust pharmaceutical R&D, sophisticated biotechnology infrastructure, and high healthcare spending. The U.S. dominates GPCR-targeted drug discovery, backed by leading biotech companies, research universities, and government grants. The increasing incidence of chronic diseases further fuels market growth in the region.
Europe is expected to grow at the fastest CAGR of the global G-protein coupled receptors market during the projected period. This is propelled by cutting-edge biomedical research, robust pharmaceutical industry presence, and growing government investment in drug discovery. Germany, the U.K., and France are at the forefront of GPCR-targeted therapeutics development. An upsurge in the prevalence of chronic diseases and partnerships among research institutions and biotech companies further drive market growth.
Company Profiling
Major vendors in the global G-protein coupled receptors market are BD, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, QIAGEN, WuXi AppTec, PerkinElmer Inc., Promega Corporation, Abcam plc, Enzo Biochem Inc., and Others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global G-protein coupled receptors market based on the below-mentioned segments:
Global G-protein Coupled Receptors Market, By Product
Global G-protein Coupled Receptors Market, By Application
Global G-protein Coupled Receptors Market, By Regional
May 2025 - The Global Car Interior Monitoring System Market Size is Expected to Grow from USD 2.47 Billion in 2023 to USD 8.61 Billion by 2033, Growing at a CAGR of 13.30% during the forecast period 2023-2033.
May 2025 - The Global Capsule Endoscopy Market Size Expected to Grow from 389.8 Million in 2023 to USD 783.8 Million by 2033, at a CAGR of 7.23% during the forecast period 2023-2033.
May 2025 - The Global Rare Kidney Diseases Treatment Market Size is Expected to Grow from USD 2.79 Billion in 2023 to USD 4.83 Billion by 2033, at a CAGR of 5.64% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
